BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 24, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Oct. 31, 2006
View Archived Issues
Long-term hepatitis C virus suppression seen with valopicitabine and peg-interferon
Read More
Bavituximab safe in phase I hepatitis C study
Read More
Phase II study shows eltrombopag efficacy in HCV-associated thrombocytopenia
Read More
Studies detail long-term hepatitis B viral suppression with telbivudine
Read More
Interferon alfacon-1/ribavirin shows promise in HCV peg-interferon nonresponders
Read More
Idenix to enhance hepatitis C pipeline through Metabasis collaboration
Read More
Daytrana shown to give individualized ADHD symptom management
Read More
Phase III study of naproxcinod in osteoarthritis meets primary endpoints
Read More
Intercell and MSD to develop prophylactic vaccine against Group A Streptococcus
Read More
Action Pharma's pipeline development supported by new venture capital
Read More
RTA-744 awarded orphan drug status for malignant gliomas
Read More
Shionogi discontinues development of S-5751
Read More
Strattera improves ADHD symptoms in subjects with reading disorder
Read More
R-7128 begins phase I study for HCV
Read More
Argos awarded NIH contract to further develop HIV immunotherapy candidates
Read More
New phase I study to investigate WT1 peptide therapeutic vaccine INNO-305
Read More
Chugai reviews highlights of third quarter
Read More
Preclinical studies of FTI tipifarnib encourage clinical investigation in HGPS
Read More
Fluphenazine decanoate to be evaluated for the management of psoriasis in phase II clinical trial
Read More
Nicotinamide protects against axonal degeneration in MS model / News in Context
Read More
Emerging natural products for the treatment of neurological disorders: Part I
Read More
New treatments for cancer covered in recent patent literature
Read More
Recent Pfizer patent describes new dopamine D2 receptor ligands for schizophrenia
Read More
Novel alpha1A/1D-adrenoceptor antagonists reported by Janssen
Read More
Novel agents for dental caries claimed by Queen Mary, University of London
Read More